BIMEKIZUMAB-BKZX for Dermatitis atopic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 31 adverse event reports in the FDA FAERS database where BIMEKIZUMAB-BKZX was used for Dermatitis atopic.
Most Reported Side Effects for BIMEKIZUMAB-BKZX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 694 | 13.0% | 0 | 24 |
| Psoriasis | 621 | 11.6% | 0 | 9 |
| Drug ineffective | 402 | 7.5% | 0 | 11 |
| Product availability issue | 364 | 6.8% | 0 | 17 |
| Off label use | 335 | 6.3% | 3 | 39 |
| Psoriatic arthropathy | 301 | 5.6% | 0 | 15 |
| Injection site pain | 263 | 4.9% | 0 | 8 |
| Therapy interrupted | 252 | 4.7% | 0 | 15 |
| Hidradenitis | 233 | 4.4% | 0 | 14 |
| Inappropriate schedule of product administration | 214 | 4.0% | 0 | 11 |
| Incorrect dose administered | 209 | 3.9% | 0 | 5 |
| Oral candidiasis | 178 | 3.3% | 0 | 9 |
| Pain | 159 | 3.0% | 1 | 5 |
| Fatigue | 148 | 2.8% | 0 | 6 |
| Headache | 146 | 2.7% | 0 | 7 |
Other Indications for BIMEKIZUMAB-BKZX
Psoriasis (3,059)
Psoriatic arthropathy (1,033)
Product used for unknown indication (716)
Hidradenitis (598)
Ankylosing spondylitis (199)
Off label use (199)
Axial spondyloarthritis (55)
Rheumatoid arthritis (39)
Illness (21)
Pustular psoriasis (20)
Other Drugs Used for Dermatitis atopic
DUPILUMAB (179,563)
UPADACITINIB (5,263)
TRALOKINUMAB-LDRM (3,007)
CRISABOROLE (2,139)
ABROCITINIB (1,616)
NEMOLIZUMAB-ILTO (1,596)
RUXOLITINIB (740)
TACROLIMUS (515)
METHOTREXATE (400)
CYCLOSPORINE (370)